VASCULAR KALLIKREIN IN DOCA-SALT HYPERTENSION

被引：0
|
作者：
NOLLY, H [1 ]
CARRETERO, OA [1 ]
SCICLI, G [1 ]
SCICLI, AG [1 ]
机构：
[1] HENRY FORD HOSP,DIV HYPERTENS & VASC RES,DETROIT,MI 48202
来源：
HYPERTENSION | 1993年 / 21卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [11] DOCA-SALT HYPERTENSION X HYDRALAZINE
    NIGRO, D
    CUMAN, R
    CARVALHO, MHC
    SCIVOLETTO, R
    FORTES, ZB
    HYPERTENSION, 1991, 17 (03) : 406 - 407
  • [12] GLOMERULAR AND VASCULAR-LESIONS IN DOCA-SALT HYPERTENSION - THE ROLE OF ANTICOAGULATION
    HEWITSON, T
    KAMITSUJI, H
    WHITWORTH, JA
    KINCAIDSMITH, P
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1988, 10 (04) : 649 - 666
  • [13] THE ROLE OF CALMODULIN IN NEUROTRANSMITTER RELEASE AND VASCULAR RESPONSIVENESS IN DOCA-SALT HYPERTENSION
    TSUDA, K
    NISHIO, I
    MASUYAMA, Y
    JOURNAL OF HYPERTENSION, 1986, 4 : S57 - S59
  • [14] Role of endothelin and vasopressin in DOCA-salt hypertension
    Yu, M
    Gopalakrishnan, V
    McNeill, JR
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (07) : 1447 - 1454
  • [15] ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension
    Callera, GE
    Touyz, RM
    Teixeira, SA
    Muscara, MN
    Carvalho, MHC
    Fortes, ZB
    Nigro, D
    Schiffrin, EL
    Tostes, RC
    HYPERTENSION, 2003, 42 (04) : 811 - 817
  • [16] COMPARISON OF THE VASCULAR AND GLOMERULAR CHANGES IN AORTIC-LIGATURE AND DOCA-SALT HYPERTENSION
    HEWITSON, T
    KAMITSUJI, H
    WHITWORTH, JA
    KINCAIDSMITH, P
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1989, 16 (08) : 641 - 645
  • [17] DEVELOPMENT OF DOCA-SALT HYPERTENSION IN THE BRATTLEBORO RAT
    SAITO, T
    YAJIMA, Y
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 394 (OCT) : 309 - 318
  • [18] Sympathetic activation in the development of DOCA-salt hypertension
    Kandlikar, Sachin
    King, Andrew J.
    Novotny, Martin
    Fink, Gregory
    FASEB JOURNAL, 2008, 22
  • [19] EFLORNITHINE (DFMO) TREATMENT AND VASCULAR POLYAMINES IN ESTABLISHED HYPERTENSION IN THE DOCA-SALT RAT
    BROWN, M
    NEWMAN, P
    TROWBRIDGE, J
    ROSE, B
    PASS, S
    FEGER, A
    GUO, H
    OLSON, J
    SOLTIS, E
    FASEB JOURNAL, 1993, 7 (04): : A548 - A548
  • [20] Role of the OVLT in the Development of DOCA-salt Hypertension
    Collister, John P.
    Nahey, David B.
    Banek, Christopher T.
    Osborn, John W.
    FASEB JOURNAL, 2017, 31
12345